SCHEMBL4464439

SCHEMBL4464439

O=S(=O)(c1cc(O)c(O)cc1F)N1CCCCC1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TSHR P16473 7/20 0.50
ALDH1A1 P00352 5/20 0.50
CYP3A4 P08684 2/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
TP53 P04637 2/20 0.47
MAPT P10636 2/20 0.47
COMT P21964 1/20 0.47
KDM4E B2RXH2 2/20 0.47
L3MBTL1 Q9Y468 3/20 0.46
GAA P10253 1/20 0.46
NPBWR1 P48145 1/20 0.46
ALOX15 P16050 1/20 0.46
MEN1 O00255 3/20 0.45
KMT2A Q03164 3/20 0.45
LMNA P02545 1/20 0.45
ATM Q13315 1/20 0.44
USP2 O75604 1/20 0.44
POLB P06746 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28254881 0.84 TSHR (0.55) TSHRALDH1A1CYP3A4CYP2C9CYP2C19
SCHEMBL6206499 0.83 CNR1 (0.52) TSHRALDH1A1MAPTKDM4EMEN1
SCHEMBL6034809 0.79 KDM4E (0.47) TSHRALDH1A1CYP3A4CYP2C9CYP2C19
SCHEMBL4468528 0.79 TSHR (0.67) TSHRALDH1A1KDM4EL3MBTL1GAA
SCHEMBL6035064 0.78 PKM (0.56) TSHRALDH1A1CYP3A4CYP2C9CYP2C19
SCHEMBL14256426 0.77 KDM4E (0.55) TSHRALDH1A1MAPTCOMTKDM4E
SCHEMBL6034233 0.77 COMT (0.45) TSHRALDH1A1CYP3A4CYP2C9CYP2C19
SCHEMBL6034241 0.76 PKM (0.58) TSHRALDH1A1CYP3A4CYP2C9CYP2C19
SCHEMBL4556004 0.76 PKM (0.71) TSHRALDH1A1CYP3A4CYP2C9CYP2C19
SCHEMBL20595150 0.76 KDM4E (0.61) TSHRALDH1A1CYP3A4CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7576088-B2 Benzodioxole derivatives HOFFMAN-LA ROCHE INC. (US) 2009-08-18 US disclosed
EP-1532132-B1 NOVEL BENZODIOXOLES HOFFMANN LA ROCHE (CH) 2008-03-19 EP disclosed
US-20050143373-A1 Benzodioxole derivatives ALANINE ALEXANDER (FR) 2005-06-30 US disclosed
US-6900227-B2 Benzodioxole derivatives HOFFMANN-LA ROCHE INC. (US) 2005-05-31 US disclosed
EP-1532132-A1 NOVEL BENZODIOXOLES F.HOFFMANN-LA ROCHE AG (CH) 2005-05-25 EP disclosed
US-20040142922-A1 Benzodioxole derivatives HOFFMANN-LA ROCHE INC. 2004-07-22 US disclosed
WO-2004013120-A1 NOVEL BENZODIOXOLES F. HOFFMANN-LA ROCHE AG (CH) 2004-02-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050143373-A1 Benzodioxole derivatives CNR2, CNR1, GPR119 TSHR 1029/4885ALDH1A1 607/4885CYP3A4 313/4885
US-20040142922-A1 Benzodioxole derivatives CNR1, CNR2, GPR119 TSHR 1171/4885ALDH1A1 299/4885CYP3A4 273/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.